These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12165753)

  • 1. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism.
    Dhossche D; Applegate H; Abraham A; Maertens P; Bland L; Bencsath A; Martinez J
    Med Sci Monit; 2002 Aug; 8(8):PR1-6. PubMed ID: 12165753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA-transaminase, the liver and infantile autism.
    Cohen BI
    Med Hypotheses; 2001 Dec; 57(6):673-4. PubMed ID: 11918424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism as early expression of catatonia.
    Dhossche DM
    Med Sci Monit; 2004 Mar; 10(3):RA31-9. PubMed ID: 14976444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT.
    Dhossche DM; Rout U
    Int Rev Neurobiol; 2006; 72():55-79. PubMed ID: 16697291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma GABA in mood disorders.
    Petty F; Kramer GL; Dunnam D; Rush AJ
    Psychopharmacol Bull; 1990; 26(2):157-61. PubMed ID: 2236451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High nitric oxide production in autistic disorder: a possible role for interferon-gamma.
    Sweeten TL; Posey DJ; Shankar S; McDougle CJ
    Biol Psychiatry; 2004 Feb; 55(4):434-7. PubMed ID: 14960298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders.
    Dhossche DM; Shah A; Wing L
    Int Rev Neurobiol; 2006; 72():267-84. PubMed ID: 16697303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced plasma apelin levels in patients with autistic spectrum disorder.
    Boso M; Emanuele E; Politi P; Pace A; Arra M; Ucelli di Nemi S; Barale F
    Arch Med Res; 2007 Jan; 38(1):70-4. PubMed ID: 17174726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy.
    Fayed N; Modrego PJ
    Acad Radiol; 2005 May; 12(5):566-9. PubMed ID: 15866128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-injury in autism as an alternate sign of catatonia: implications for electroconvulsive therapy.
    Wachtel LE; Dhossche DM
    Med Hypotheses; 2010 Jul; 75(1):111-4. PubMed ID: 20202760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imbalance of plasma amino acids in patients with autism and subjects with attention deficit/hyperactivity disorder].
    Zavala M; Castejón HV; Ortega PA; Castejón OJ; Marcano de Hidalgo A; Montiel N
    Rev Neurol; 2001 Sep 1-15; 33(5):401-8. PubMed ID: 11727202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum.
    Richardson AJ; Ross MA
    Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):1-9. PubMed ID: 10970706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could ECT be effective in autism?
    Dhossche DM; Stanfill S
    Med Hypotheses; 2004; 63(3):371-6. PubMed ID: 15288351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autistic disorder symptoms in Rett syndrome.
    Wulffaert J; Van Berckelaer-Onnes IA; Scholte EM
    Autism; 2009 Nov; 13(6):567-81. PubMed ID: 19933764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism.
    Pastural E; Ritchie S; Lu Y; Jin W; Kavianpour A; Khine Su-Myat K; Heath D; Wood PL; Fisk M; Goodenowe DB
    Prostaglandins Leukot Essent Fatty Acids; 2009 Oct; 81(4):253-64. PubMed ID: 19608392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.
    Eppright TD; Sanfacon JA; Horwitz EA
    Mo Med; 1996 Mar; 93(3):136-8. PubMed ID: 8867271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum markers of inflammation in autism.
    Zimmerman AW; Jyonouchi H; Comi AM; Connors SL; Milstien S; Varsou A; Heyes MP
    Pediatr Neurol; 2005 Sep; 33(3):195-201. PubMed ID: 16139734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAergic dysfunction in mood disorders.
    Brambilla P; Perez J; Barale F; Schettini G; Soares JC
    Mol Psychiatry; 2003 Aug; 8(8):721-37, 715. PubMed ID: 12888801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.